Restless Legs Syndrome is a neurological sensorimotor disorder characterised by an urge to move the legs, usually accompanied by uncomfortable or unpleasant sensations. The symptoms typically begin or become worse during periods of rest or inactivity, are temporarily relieved by movement and are more prominent during the evening or night. The sensations can be difficult to describe and may include crawling, pulling, aching, tingling, tension or an internal feeling of discomfort rather than straightforward pain. The condition can interfere with falling asleep and maintaining sleep, thereby producing secondary daytime tiredness or sleepiness.
The characteristic pattern of Restless Legs Syndrome distinguishes it from many ordinary forms of leg discomfort. Symptoms tend to occur when sitting, lying down or otherwise remaining still, whereas movement such as walking or stretching often provides temporary relief. Symptoms commonly follow a circadian pattern, becoming stronger later in the day and at night. This timing can interfere with sleep onset and may lead a person to repeatedly move the legs or get out of bed. The disorder can therefore be experienced primarily as an urge to move rather than as a conventional sleep complaint, even though its consequences frequently involve sleep disruption.
Restless Legs Syndrome is associated with altered dopamine-related signalling and abnormalities involving brain iron metabolism, although its biological mechanisms are not completely understood. Iron is important to several neurological processes, and low body iron stores can be associated with symptoms in some individuals. The condition can occur without an obvious underlying cause, often described as primary or idiopathic disease, while secondary forms can be associated with circumstances such as iron deficiency, pregnancy, kidney disease and certain medications. Genetic factors also contribute, with family history being common in many cases.
Restless Legs Syndrome can occur at any age, but prevalence generally increases with age and symptoms can vary over time. Pregnancy can provoke or worsen symptoms, with improvement often occurring after delivery. Symptoms may be intermittent or persistent and can range from mildly irritating to severely disruptive. A person may also experience periodic limb movements during sleep, involving repeated involuntary limb movements that occur without conscious awareness. Restless Legs Syndrome and periodic limb movements are related but are not identical: one is primarily defined by symptoms while awake and at rest, whereas the other is a sleep-related movement phenomenon detected clinically or through sleep testing.
Diagnosis is primarily clinical and depends on the characteristic symptom pattern rather than a single laboratory test. Clinicians consider whether the urge to move occurs during rest, whether movement relieves it, whether symptoms have a circadian pattern and whether another condition better explains the sensations. Assessment may include blood tests, particularly evaluation of iron status, when clinically appropriate. A sleep study is not routinely required simply to diagnose Restless Legs Syndrome, although polysomnography can sometimes be useful when another sleep disorder is suspected or when periodic limb movements require assessment.
Management depends on severity, frequency and underlying contributors. Correcting iron deficiency when present can be important, and clinicians may review medicines or substances that can worsen symptoms. Some antihistamines, certain antidepressant medicines and other agents can aggravate symptoms in susceptible individuals, although medication changes should be made with appropriate medical guidance. Regular physical activity may be useful for some people, while excessive or very late strenuous exercise can aggravate symptoms in others. Sleep scheduling and reduction of factors that disturb sleep can also help manage the consequences of the condition.
Pharmacological treatment has evolved as understanding of the disorder has developed. Dopamine-related medicines can reduce symptoms but may cause augmentation, a clinically important phenomenon in which symptoms begin earlier in the day, become more intense, spread to other body regions or occur after progressively shorter periods of rest. Because of this issue, long-term treatment strategies require careful clinical monitoring. Other medication classes can be used depending on the individual circumstances, and treatment decisions consider symptom severity, iron status, comorbidities, adverse effects and the risk of augmentation.
A common misconception is that Restless Legs Syndrome is simply habitual fidgeting or nervousness. The defining urge to move is neurological and follows a characteristic relationship with rest, movement and circadian timing. It should also not be confused with ordinary muscle cramps, positional discomfort, peripheral neuropathy or anxiety-related movement, although these conditions can coexist. The condition matters because repeated evening discomfort can substantially disrupt sleep even when the person does not consciously recognise that the movement-related symptoms are responsible for their poor sleep.
